283 related articles for article (PubMed ID: 21367676)
1. Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of sunitinib (SU11248) and its active metabolite, N-desethyl sunitinib (SU12662), in human plasma: application to an explorative study.
Rodamer M; Elsinghorst PW; Kinzig M; Gütschow M; Sörgel F
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):695-706. PubMed ID: 21367676
[TBL] [Abstract][Full Text] [Related]
2. Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry.
de Bruijn P; Sleijfer S; Lam MH; Mathijssen RH; Wiemer EA; Loos WJ
J Pharm Biomed Anal; 2010 Mar; 51(4):934-41. PubMed ID: 19931354
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
Rais R; Zhao M; He P; Xu L; Deeken JF; Rudek MA
Biomed Chromatogr; 2012 Nov; 26(11):1315-24. PubMed ID: 22259028
[TBL] [Abstract][Full Text] [Related]
4. A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine.
Marangon E; Buzzo M; Posocco B; Gagno S; Zanchetta M; Iacuzzi V; Poetto AS; Guardascione M; Giodini L; Toffoli G
J Pharm Biomed Anal; 2020 Feb; 179():112949. PubMed ID: 31784210
[TBL] [Abstract][Full Text] [Related]
5. Determination of sunitinib and its active metabolite, N-desethyl sunitinib in mouse plasma and tissues by UPLC-MS/MS: assay development and application to pharmacokinetic and tissue distribution studies.
Chen X; Wang Z; Liu M; Liao M; Wang X; Du H; Chen J; Yao M; Li Q
Biomed Chromatogr; 2015 May; 29(5):679-88. PubMed ID: 25294592
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a liquid chromatography-tandem mass spectrometry for the determination of BPR0L075, a novel antimicrotuble agent, in rat plasma: application to a pharmacokinetic study.
Chang YW; Chen WC; Lin KT; Chang L; Yao HT; Hsieh HP; Lan SJ; Chen CT; Chao YS; Yeh TK
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):162-8. PubMed ID: 17005456
[TBL] [Abstract][Full Text] [Related]
7. An LC-MS/MS procedure for the quantification of naproxen in human plasma: development, validation, comparison with other methods, and application to a pharmacokinetic study.
Elsinghorst PW; Kinzig M; Rodamer M; Holzgrabe U; Sörgel F
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1686-96. PubMed ID: 21536505
[TBL] [Abstract][Full Text] [Related]
8. Quantification of sunitinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Minkin P; Zhao M; Chen Z; Ouwerkerk J; Gelderblom H; Baker SD
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):84-8. PubMed ID: 18823825
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of sunitinib and its two metabolites in plasma of Chinese patients with metastatic renal cell carcinoma by liquid chromatography-tandem mass spectrometry.
Qiu F; Bian W; Li J; Ge Z
Biomed Chromatogr; 2013 May; 27(5):615-21. PubMed ID: 23108983
[TBL] [Abstract][Full Text] [Related]
10. Determination of silodosin in human plasma by liquid chromatography-tandem mass spectrometry.
Zhao X; Liu Y; Xu J; Zhang D; Zhou Y; Gu J; Cui Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3724-8. PubMed ID: 19782650
[TBL] [Abstract][Full Text] [Related]
11. An HPLC method for simultaneous quantification of sunitinib and its active metabolite, SU12662, using hydrophilic interaction chromatography principle.
Gurjar M; Mehta P; Sharma J; Patil S; Kulkarni P; Patil A; Nookala M; Joshi A; Gota V
Bioanalysis; 2020 Jan; 12(2):75-85. PubMed ID: 31928228
[No Abstract] [Full Text] [Related]
12. Determination of sunitinib in human plasma using liquid chromatography coupled with mass spectrometry.
Musijowski J; Piórkowska E; Rudzki PJ
J Sep Sci; 2014 Oct; 37(19):2652-8. PubMed ID: 25044855
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of SU1 1248, an oral multi-target tyrosine kinase inhibitor, and its metabolite in monkey tissues by liquid chromatograph with tandem mass spectrometry following semi-automated liquid-liquid extraction.
Barattè S; Sarati S; Frigerio E; James CA; Ye C; Zhang Q
J Chromatogr A; 2004 Jan; 1024(1-2):87-94. PubMed ID: 14753710
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of subutinib and its active metabolite in human plasma by LC-MS/MS: Application to pharmacokinetic study.
Ding LK; Yang L; Chen SN; Li JK; Wen AD
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():22-6. PubMed ID: 26253807
[TBL] [Abstract][Full Text] [Related]
16. Validation of a liquid chromatography-triple quadrupole mass spectrometric method for the determination of 5-nitro-5'-hydroxy-indirubin-3'-oxime (AGM-130) in human plasma and its application to microdose clinical trial.
Park MH; Lee YY; Cho KH; La S; Lee HJ; Yim DS; Ban S; Park MY; Kim YC; Kim YG; Shin YG
Biomed Chromatogr; 2016 Mar; 30(3):323-9. PubMed ID: 26139072
[TBL] [Abstract][Full Text] [Related]
17. Quantification of sunitinib and N-desethyl sunitinib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry: validation and application in routine therapeutic drug monitoring.
Lankheet NA; Steeghs N; Rosing H; Schellens JH; Beijnen JH; Huitema AD
Ther Drug Monit; 2013 Apr; 35(2):168-76. PubMed ID: 23503442
[TBL] [Abstract][Full Text] [Related]
18. The influence of light sources on sunitinib measurements with photoisomerization.
Matsunaga N; Kitahara T; Yamada M; Sato K; Kodama Y; Sasaki H
Biomed Chromatogr; 2019 Feb; 33(2):e4407. PubMed ID: 30315654
[TBL] [Abstract][Full Text] [Related]
19. Sensitive and accurate liquid chromatography-tandem mass spectrometry methods for quantitative determination of a novel hepatitis C NS5B inhibitor BMS-791325 and its active metabolite in human plasma and urine.
Jiang H; Demers R; Kandoussi H; Burrell R; Eley T; Kadiyala P; Cojocaru L; Baker C; Ryan J; Aubry AF; Arnold ME; Zeng J
J Pharm Biomed Anal; 2015 Mar; 107():17-23. PubMed ID: 25562845
[TBL] [Abstract][Full Text] [Related]
20. Quantification of cyclizine and norcyclizine in human plasma by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Jensen BP; Vella-Brincat JW; Begg EJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Mar; 879(9-10):605-9. PubMed ID: 21333615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
